Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 297
Filter
Add filters

Year range
5.
NeuroQuantology ; 20(10):7763-7772, 2022.
Article in English | EMBASE | ID: covidwho-2067319

ABSTRACT

Insurance is one of the service sectors which play the vital role in quality based services. This sector consists of all types of financial activities such as banking and trade of securities. Insurance covers many aspects of assurance on life, medical and insurance on general aspects. Health insurance is an instrument that supports monetary requirements at the time of uncertainty faced by the insurer. Over the past few decades, India’s achievement in terms of healthy survival consciousness has been significant but health insurance sectors are still the way behind while comparing with many other similar countries. Covid-19 impact created prerequisite of health insurance. The purpose of the study is to highlight the factors for choosing the health insurance and personality traits on perception of health insurance. The study investigated the survey through the structured questionnaire and applied convenience sampling method. The SPSS statistical tool was employed to draw the results from the 100 respondents. Descriptive statistics, Anova, Correlation, Regression and Factor analysis are applied to infer the results. The study identified three variables like, Assurance, convenience, responsiveness and satisfaction as service quality. This study concluded that convenience and responsiveness has significantly correlated. Challenges and personality traits are perfectly correlated. Finally, the result shows that personality traits have an impact on buying behaviour of health insurance.

6.
American Journal of Transplantation ; 22(Supplement 3):528, 2022.
Article in English | EMBASE | ID: covidwho-2063394

ABSTRACT

Purpose: Alcohol use after liver transplant is associated with higher rates of graft loss and increased mortality;however, there is limited data regarding the factors that influence biochemically confirmed relapse. We aimed to evaluate the association between social determinants of health (SDOH) and biochemical alcohol relapse in patients who have been transplanted for alcohol-associated liver disease (ALD). Method(s): This single-center, retrospective cohort study examined patients with ALD who were transplanted between 2018-2021. The primary outcome was biochemical alcohol relapse as measured by systematic phosphatidylethanol (PEth) testing. SDOH including race, ethnicity, income, employment, social support, education level, public vs private health insurance, mental health comorbidities, and comorbid illicit substance use were assessed for their association with the outcome using logistic regression analyses. Additionally, temporal trends in biochemical relapse related to the Covid-19 pandemic were evaluated using a cut point of April 2020 to differentiate between pre-pandemic and pandemic groups. Result(s): Seventy-five patients were transplanted for ALD over the study period, of whom 71 had biochemical PEth measurements (95%). Of these 71 patients, 21% were female with a mean (+/-SD) age of 52.9 (+/-10.4) years and 49% of the study population identified as Hispanic ethnicity. At the time of transplant listing, 73% were unemployed, 65% had public insurance, and 62% were married or had a stable co-companion. Over 64 person-years of follow up, 10 (15%) patients had biochemical relapse after transplant. Older age was protective OR=0.94 (95% CI 0.88-0.99;p=0.05), while non-Hispanic white race OR=6.29 (95% CI 1.22-32.51;p=0.03), and prior illicit substance use OR=4.2 (95% CI 1.05-16.90;p=0.04) were associated with an increased risk of relapse. Patients identifying as non-Hispanic white had non-significant trends toward lower household income, decreased social support, and higher rates of comorbid mental illness. Severe acute alcohol hepatitis, time from last drink to listing, SIPAT and AUDIT score were not associated with increased risk of relapse. The risk of relapse increased during the Covid-19 pandemic from 4.3% pre-Covid-19 to 18.8% during Covid-19 with a trend towards statistical significance OR=5.1 (95% CI 0.60-42.8;p=0.13). Conclusion(s): Non-Hispanic white race, younger age, and illicit substance use were associated with increased rates of biochemical alcohol relapse and may be explained by SDOH;however, conventional metrics including >6 months from last drink to listing and lower SIPAT score were not predictive of biochemical relapse.

7.
Pharmaceutical Journal ; 306(7949), 2022.
Article in English | EMBASE | ID: covidwho-2064963
8.
Investigative Ophthalmology and Visual Science ; 63(7):2230-A0526, 2022.
Article in English | EMBASE | ID: covidwho-2058415

ABSTRACT

Purpose : Patients on systemic immunomodulatory therapy (IMT) for uveitis are at higher risk of infection and infectious complications. While other medical specialties have studied the safety of IMT in non-ocular, autoimmune conditions vis-à-vis coronavirus disease 2019 (COVID-19), little is known about the effects of these drugs in uveitis patients specifically. The objective of this study was to determine if uveitis patients with COVID-19 were at higher risk of hospitalization for this pandemic illness and whether systemic IMT affected this risk. Methods : Retrospective cohort study of uveitis patients in 2020 in the United States. The Symphony health insurance claims dataset was used. Inclusion criteria were an ICD10 code for COVID-19, a code for any form of non-infectious uveitis or scleritis, and age 18 or greater. Drugs studied included methotrexate, mycophenolate, azathioprine, tacrolimus, cyclosporine, adalimumab, infliximab, tocilizumab, rituximab, and JAK, IL-17, and IL-12/23 inhibitors. The main outcome measure was adjusted odds of hospitalization for COVID19. Multivariable logistic regression was used to adjust for major risk factors for severe COVID-19 disease, including age, biological sex, cardiac, pulmonary, hepatic, and renal disease, obesity, organ transplant, stroke, and certain cancers. Results : 3,974,272 patients in the dataset were diagnosed with COVID-19 in 2020. Of these, 6389 (0.16%) had established diagnoses of uveitis or scleritis. Within the uveitis group, mean age was 54 years (SD 16), and 62% were female. 708 (11.1%) of the uveitis patients were hospitalized for COVID-19, significantly greater than the 7.3% rate amongst all adult, COVID-19-positive patients in the dataset (p < 0.001) and the CDC estimate of 7.5% for the US population in 2020 (p < 0.001). No agent showed a statistically significant effect on hospitalization. The higher rate of hospitalization in uveitis patients was partly, though not completely, explained by higher rates in uveitis-associated autoimmune conditions in the dataset as a whole. Conclusions : Uveitis patients have a greater risk of hospitalization for COVID-19 compared with the general population. As a whole, conventional IMT and biologics do not increase the risk of COVID-19 hospitalization amongst uveitis patients infected with the virus.

9.
Investigative Ophthalmology and Visual Science ; 63(7):2155-A0183, 2022.
Article in English | EMBASE | ID: covidwho-2058317

ABSTRACT

Purpose : The effect of coronavirus disease 2019 (COVID-19) on ophthalmic surgical case numbers in Australia and globally remains poorly characterised. Increased incidence of COVID-19 in Australia between March and April 2020 led to a national lockdown and elective surgery restrictions. The aim of this population-based study was to quantify the early impact of COVID-19 on ophthalmic surgery in Australia, comparing surgical service rates in 2019 and 2020. Methods : Retrospective analysis of the number of ophthalmic surgical services in 2019 and 2020 in all Australian States and Territories, as recorded by Medicare (Australian Government-funded universal health insurance scheme subsidising healthcare costs for Australian residents). Monthly surgical service rates were calculated and Poisson regression was used to compare the change in service rates between months. Results : Between March and April 2020, surgical service rates decreased for: cataract surgery (by 71%, 95% CI: 70-72%), cataract surgery with minimally invasive glaucoma surgical device insertion (by 71%, 95% CI: 65-75%), pterygium removal (by 67%, 95% CI: 60- 72%), corneal transplantation (by 31%, 95% CI: 9-48%), and collagen crosslinking for corneal ectasias (by 35%, 95% CI: 18-48%). Comparatively, service rates for these surgeries did not differ or decreased less between March and April 2019. Interestingly, glaucoma filtration surgery rates decreased between March and April in 2020 (by 44%, 95% CI: 29- 56%) and also in 2019 (by 45%, 95% CI: 31-55%), whilst retinal detachment surgery rates were unchanged between these months in 2020 (crude decrease 9%, 95% CI: -28 to 16%) and 2019 (crude decrease 11%, 95% CI: -26 to 9%). Conclusions : Despite relatively low rates of COVID-19 community transmission in Australia in 2020, ophthalmic surgical service rates decreased during months in lockdown and with restrictions, largely for non-time-critical conditions. These data may have health planning implications as the pandemic continues, with future lockdowns and restrictions possible, especially as COVID-19 variants emerge.

10.
Investigative Ophthalmology and Visual Science ; 63(7):2146-A0174, 2022.
Article in English | EMBASE | ID: covidwho-2058033

ABSTRACT

Purpose : To explore associations between sensory impairment (vision and/or hearing) and Coronavirus disease 2019 (COVID-19) in the adult 2020 California Health Interview Survey (CHIS) population. Methods : A cross-sectional study was conducted using the 2020 CHIS, the nation's largest state health survey with a sample representative of the population of California. The exposure of interest was having sensory impairment, defined as answering “Yes” to the question, “Are you blind or deaf, or do you have a severe vision or hearing problem?” The outcome of interest was whether a health professional suspected the respondent had COVID-19, assessed among those adults who had or thought they had COVID-19 and contacted a health professional. Logistic regression models were constructed to determine the odds of suspected COVID-19 by sensory impairment status, controlling for the following covariates: age, sex, race/ethnicity, self-reported general health status, current smoking habits, overweight/obese body mass index, and current health insurance status. All analyses were weighted according to the CHIS sampling design. Results : A total of 21,949 sampled participants were included, representing a weighted estimate of 29,684,882 individuals. The weighted prevalence of sensory impairment was 5.9% (95% confidence interval [CI] 5.4-6.4%). Approximately 10.9% (95% CI: 10.3-11.6%) of all participants had or thought they had COVID-19, 4.9% (95% CI: 4.5-5.3%) contacted a health professional about COVID-19 concerns, and 1.7% (95% CI: 1.4-2.0%) were suspected of having COVID-19 by a health professional. Regression analyses were performed in a subgroup of 988 participants representing 1,431,690 individuals who had or thought they had COVID-19 and contacted a health professional. Those with sensory impairment had 2.12 times the unadjusted odds of suspected COVID-19 compared to those without sensory impairment (odds ratio [OR]: 2.12, 95% CI: 0.98-4.63). Those with sensory impairment had 2.51 times the adjusted odds of suspected COVID-19 compared to those without sensory impairment (adjusted OR: 2.51, 95% CI: 1.03-6.10). Conclusions : In the 2020 CHIS adult population, individuals with vision and/or hearing impairment had greater odds of having COVID-19 suspected by a health professional. Additional studies are necessary to triangulate these findings and further explore this possible increased risk for COVID-19 in this vulnerable population.

11.
Investigative Ophthalmology and Visual Science ; 63(7):2789-A0119, 2022.
Article in English | EMBASE | ID: covidwho-2057981

ABSTRACT

Purpose : Health systems' responses to the coronavirus disease 2019 (COVID-19) pandemic created a surgical backlog of unknown size, limiting the ability to develop strategies to effectively address the backlog. We assessed the volume of deferred ophthalmic surgeries associated with the COVID-19 pandemic from March-December 2020 and suggested strategies and duration to clear the backlog in Ontario, Canada. Methods : Ontario Health Insurance Plan physician billing data from 2017-2020 were analyzed. The ophthalmic surgical backlog associated with the pandemic was estimated using time series forecasting models on training set (115 weeks), validation set (52 weeks) and forecasting set (42 weeks). Clearance time was calculated based on the queuing theory using various scenarios. Results : In 2020, there were 5.13 million ophthalmologist services, a reduction of 22% compared to the 6.60 million services in 2019. This included a 27% decrease in ophthalmic surgeries that require the use of operating rooms (OR) and a 6% decrease in anti-VEGF (vascular endothelial growth factor) injections (a common procedure for macular degeneration) that can be done in clinics. From March 16 to December 31, 2020 (a pandemic period), the estimated backlog in ophthalmic surgeries requiring an OR was 92,150 surgeries (95% prediction interval [PI] 71,288-112,841), increasing on average by 2,194 surgeries per week. Roughly 90% of the delayed surgeries were cataract surgeries and 4% were retinal detachment surgeries. Nearly half of the provincial backlog (48%, 44,542/92,150) involved patients from the West health region. Estimated provincial clearance time was 248 weeks (95% confidence interval [CI] 235-260) and 128 weeks (95% CI 121-134) if 10% and 20% of OR surgical capacity per week were added, respectively, based on the weekly ophthalmic surgical volume in 2019. Furthermore, an estimated 23,755 (95% PI 14,656-32,497) anti-VEGF injections were missed. Conclusions : The magnitude of ophthalmic surgical backlog in Ontario in 2020 alone raises serious concerns for meeting the ophthalmic surgical needs of patients. As the pandemic continues the accrued backlog size is likely increasing. Planning and actions are needed urgently to manage the collateral impact of the pandemic on the ophthalmic surgical backlog in Ontario.

12.
Investigative Ophthalmology and Visual Science ; 63(7):1421-A0117, 2022.
Article in English | EMBASE | ID: covidwho-2057824

ABSTRACT

Purpose : Limited access to eye-care among Latinos can lead to missed Vision Threatening Diseases (VTDs) defined as Age-related Macular Degeneration (AMD), cataracts, Diabetic Retinopathy (DR) and glaucoma. As 50% of the people with VTD's are unaware of their condition made worse during COVID-19, comprehensive eye screenings to assess ocular wellness was implemented using telemedicine, Artificial Intelligence (AI) and robotic consultations. Methods : State-sponsored screenings were conducted at a church in West New York, NJ (78% Latino, mostly from Colombia) over 3 weekends during the 2021 Pandemic. All participants had received two-dose vaccinations and wore a surgical mask during screenings. Nine first-year medical students and 6 community volunteers took part in the wellness evaluation including: medical history, blood pressure, visual acuity, automated refraction, puff tonometry, 45-degree non-mydriatic retinal photography AI. To confirm findings: 6-micron resolution ocular coherence tomography (OCT) B-scan was performed. Screened subjects had their data reviewed by an onsite ophthalmic grader using a Spanish-speaking interpreter. As 80% of screened subjects are lost to follow-up, remote robotic ophthalmology consultation via HIPAA compliant Wi-Fi was utilized in real-time to connect with an off-site ophthalmologist. Results : 153 subjects, (71 Female (46%), median age 55) had 127 ocular findings (Table 1) found in 85 (55%) subjects, of which 98% of findings were previously unknown and 40 (47%) classified as VTD. 23(15%) subjects had multiple findings. OCT confirmed 23 cases of AMD and glaucoma. AI referred 39 cases. 36 individuals took part in robotic virtual consults. Findings were: cataracts 70 (45%), glaucoma 32 (20%), and AMD 25(16%). Among those with findings, 82% were uninsured and 90% had >2 years since last eye exam. 32 (32/153) subjects had undertreated or untreated hypertension. 93% were un-familiar with telemedicine. Conclusions : Latinos without health insurance and ease of access to eyecare may have a higher burden of multi-VTDs. An exception was DR which could be a limitation of population bias. This pilot study supports comprehensive wellness eye screenings that may allow for early detection, confirmation, and referral of single or multiple VTD in high-risk low-income communities. Further studies are needed using larger sample populations. (Figure Presented).

13.
Investigative Ophthalmology and Visual Science ; 63(7):1631-A0126, 2022.
Article in English | EMBASE | ID: covidwho-2057724

ABSTRACT

Purpose : The mental health burden of the COVID-19 pandemic is thought to be substantial. Glaucoma patients are especially vulnerable considering prior reports of higher rates of anxiety and depression than the general population at baseline. In this study, we explore how measures of mental health and social support during the pandemic varied by gender among those diagnosed with glaucoma. Methods : We obtained a cohort of patients diagnosed with glaucoma (any type) from the NIH All of US Research Program. Answers from the latest COVID-19 Participant Experience (COPE) survey were used. Logistic regression was used to evaluate the association between reported depression (using Patient Health Questionnaire-9 (PHQ-9) scores), stress associated with social distancing, and measures of social support if one became sick with COVID-19 by self-reported gender (male, female, other). Multivariable models were adjusted for age, race/ethnicity, health insurance status, education, and income, with males as the reference group. Observations with missing values for covariates used in the models were dropped. Results : Of 3,675 glaucoma patients, 56.1% were female, 83.4% were non-Hispanic White, and 95.0% had insurance plans other than Medicaid or none. Many patients had a PHQ-9 score >4 (33.5%), indicating mild, moderate, or severe depression, and 74.4% experienced “a lot” or “some” stress during the pandemic from social distancing. After adjusting for covariates, females were more likely to report depression (OR: 1.40, 95% CI: 1.20-1.62) and stress associated with social distancing (OR: 1.34, 95% CI: 1.14-1.57) than males. Further, females were less likely to report having help if they were sick with COVID-19 and needed someone to prepare meals (OR: 0.78, 95% CI: 0.67-0.92) or help with daily chores (OR: 0.79, 95% CI: 0.67-0.91). Conclusions : Females with glaucoma were more likely to experience depression, stress due to social distancing, and were less likely to have social support if sick with COVID-19 than their male counterparts. As measures of mental wellbeing and social support are associated with better medication adherence and health outcomes, glaucoma patients identifying as female may represent an especially vulnerable population. Efforts should be made to identify glaucoma patients experiencing hardship during the COVID-19 pandemic.

14.
Osteologie. Conference: Jahreskongress DVO OSTEOLOGIE ; 30(3), 2022.
Article in English, German | EMBASE | ID: covidwho-2057510

ABSTRACT

The proceedings contain 79 papers. The topics discussed include: vertebral fractures increase the risk of subsequent vertebral fractures: results from a large German health insurance dataset;analysis of bone architecture using fractal-based TX-Analyzer in adult patients with osteogenesis imperfecta;bone health in nursing home residents in Germany - do we care enough?;types of therapeutic errors in the management of osteoporosis: results of an experimental study;cysteine-rich angiogenic inducer 61 as a tool to efficiently enrich myeloid angiogenic cells from peripheral blood;response of bone tissue to ostarine treatment and/or treadmill exercise in a healthy adult rat model;influence of the cell aggregation technique on the differentiation of human articular chondrocytes in microtissues;changes in dispensing of anti-osteoporotic drugs during COVID-19 pandemic;and loss of adipogenic dickkopf-1 increases trabecular and cortical bone mass by promoting bone formation in male mice.

15.
Gesundheitswesen, Supplement ; 84(8-9), 2022.
Article in German | EMBASE | ID: covidwho-2057362

ABSTRACT

The proceedings contain 380 papers. The topics discussed include: precarious work as risk factor for 5-year increase in depressive symptoms among 2,009 employees in Germany;physical health, wellbeing, and the impact of the Covid-19 pandemic in older adults: results from the LAB60 + Study in Dresden;identifying relevant psychosocial factors in the care of people with dementia: findings of a focus group study with informal caregivers and health professionals;perception of health system responsiveness in Germany among patients with private health insurance;association of modifiable lifestyle factors with cognitive function in the AgeWell.de-trial;factors associated with the interest in smartphone apps for health promotion and disease prevention: results from a cross-sectional, nationwide survey in Germany;mortality, morbidity and health-related outcomes in informal caregivers compared to non-caregivers: a systematic review;the concept auf urban soundscapes in the context of alternative small-scale mobility interventions - the Be-MoVe Project;and WICID 2.0: a framework to integrate evidence and ethics in decision-making and guideline development on non-pharmacological interventions targeting COVID-19 - development and validation.

16.
Infection ; 2022 Sep 27.
Article in English | MEDLINE | ID: covidwho-2048641

ABSTRACT

INTRODUCTION: Objectives of this study, as part of a nation-wide HIV pre-exposure prophylaxis (PrEP) evaluation project, were to determine the incidence of infections with HIV, chlamydia, gonorrhea, syphilis, hepatitis A/B/C in persons using PrEP, and to describe the health care funded PrEP use in Germany. Additionally, factors associated with chlamydia/gonorrhea and syphilis infections were assessed. METHODS: Anonymous data of PrEP users were collected at 47 HIV-specialty centers from 09/2019-12/2020. Incidence rates were calculated per 100 person years (py). Using longitudinal mixed models, we analyzed risk factors associated with sexually transmitted infections (STIs). RESULTS: 4620 PrEP users were included: 99.2% male, median age 38 years (IQR 32-45), 98.6% men who have sex with men (MSM). The median duration of PrEP exposure was 451 days (IQR 357-488), totaling 5132 py. Four HIV infections were diagnosed, incidence rate 0,078/100py (95% CI 0.029-0.208). For two, suboptimal adherence was reported and in the third case, suboptimal adherence and resistance to emtricitabine were observed. One infection was likely acquired before PrEP start. Incidence rates were 21.6/100py for chlamydia, 23.7/100py for gonorrhea, 10.1/100py for syphilis and 55.4/100py for any STI and decreased significantly during the observation period. 65.5% of syphilis, 55.6% of chlamydia and 50.1% of gonorrhea cases were detected by screening of asymptomatic individuals. In a multivariable analysis among MSM younger age, PrEP start before health insurance coverage and daily PrEP were associated with greater risk for chlamydia/gonorrhea. Symptom triggered testing and a history of STI were associated with a higher risk for chlamydia/gonorrhea and syphilis. A significantly lower risk for chlamydia/gonorrhea and syphilis was found for observations during the COVID-19 pandemic period. CONCLUSIONS: We found that HIV-PrEP is almost exclusively used by MSM in Germany. A very low incidence of HIV infection and decreasing incidence rates of STIs were found in this cohort of PrEP users. The results were influenced by the SARS-CoV-2 pandemic. Rollout of PrEP covered by health insurance should be continued to prevent HIV infections. Increased PrEP availability to people at risk of HIV infection through the elimination of barriers requires further attention. Investigation and monitoring with a longer follow-up would be of value.

17.
Journal of Corporation Law ; 47(3):843-859, 2022.
Article in English | ProQuest Central | ID: covidwho-2047002

ABSTRACT

[...]this Note argues that health insurers should take a more meaningful role in complying with and promoting mental health well-being. By the 1980s, any progress made up to that point was soon after undetectable.24 President Bill Clinton later considered mental health parity during his healthcare reform efforts in 1993,25 but these efforts were equally unsuccessful.26 It was only in 1996 that Senators Pete Domenici and John Danforth introduced the first round of momentous federal parity legislation known as The Mental Health Parity Act of 1996 (MHPA).27 Although the MHPA was a compromised version of the more extensive 1992 Domenici-Wellstone bill, it nonetheless was the first of its kind and a sign of things to come.28 According to the MHPA, insurers were prohibited from imposing disparate annual and lifetime limits for mental health benefits when compared to surgical and medical benefits as offered by a group health plan or health insurance issuer offering coverage in connection with a group health plan.29 While this meant that insurers could no longer stymie access to mental health services by providing unequal coverage under a plan, the MHPA contained certain important exceptions. Rather, it only applied to group health plans that offered mental health benefits at the outset, and it did not apply to employers with fewer than 50 employees.30 Moreover, insurers were free to charge different copays and coinsurance rates.31 Lastly, employers could request exempt status from any requirements if they could show a one percent increase in premiums.32 a. The Mental Health Parity and Addiction Equity Act To combat the vast shortcomings of the MHPA,33 Congress eventually passed the Mental Health Parity and Addiction Equity Act in 2008 (MHPAEA).34 This newly enacted law prohibited differences in treatment options as well as certain cost-sharing schemes insurers previously engaged in under the MHPA. [...]according to the MHPA, insurers could set daily limits on outpatient mental health services, set their own coinsurance rates (including co-pays, deductibles, and out-of-pocket maximums), and limit treatment benefits irrespective of any parity considerations.35 Nonetheless, despite these additional requirements, the MHPAEA did not require that health insurers provide coverage for any type of mental health services.36 b. The Affordable Care Act Beyond providing health care for 20 million previously uninsured Americans, the Affordable Care Act (ACA) set the stage for what would become the largest development in access to mental health services this country has ever seen.37 Most notably, the ACA defined "mental health and substance use treatment" as an essential health benefit (EHB)38 and required individual and small-group plans to cover all EHBs.39 As previously noted, the MHPAEA only applied to large employers (50 or more employees) and only if they chose to provide mental health coverage.

18.
IAENG International Journal of Computer Science ; 49(3), 2022.
Article in English | Scopus | ID: covidwho-2046528

ABSTRACT

Healthcare is the most crucial sector in people’s life. Many applications and systems have been proposed to improve the healthcare area. The outbreak of the novel coronavirus Covid19 turns more focus on healthcare applications. To manage medical data, healthcare professionals in developed countries have adopted several electronic healthcare information systems and technologies in recent years. However, these technologies show serious privacy risks and security issues, especially in the transfer of data and the recording of data transactions. Furthermore, the high cost of these technologies acquisition, as well as the complexity of their management, make their application in underdeveloped nations extremely problematic. This article proposes a solution based on a decentralized Blockchain architecture to reinforce the security of health information systems. This solution is particularly recommended for developing countries which lack high-tech infrastructures and suffer from poor interoperability between existing information systems. Various researches and works that implement blockchainbased solutions in the security of electronic health information systems (eHIS) are discussed in this article. A new approach based on a hyperledger fabric, implementing smart contracts and several other components is proposed. The suggested architecture involves many actors who can interact with medical records such as patients, doctors, pharmacists, laboratories and insurance companies. Data privacy is guaranteed because there is minimal risk of unauthorized access entities, and by design, the smart contract is the sole way to manipulate participant data. Various optimization and measurement experiments were carried on. The results covering various key parameters of system performance such as throughput, latency, CPU usage, memory consumption and network usage are presented © 2022,IAENG International Journal of Computer Science.All Rights Reserved

20.
American Journal of Public Health ; 112:S574-S575, 2022.
Article in English | ProQuest Central | ID: covidwho-2045422

ABSTRACT

The pandemic has highlighted the need for countries to work together on scientific evidence production and vaccine development and elucidated the commonality of pandemic-related challenges, such as personal protective equipment unavailability and supply chain disruptions. In a groundbreaking study named HEROES (COVID-19 Health Care Workers Study), Paniagua-Avila et al. (p. S602) describe the prevalence of mental health conditions and associated exposures during the COVID-19 pandemic in a Guatemalan cohort of health workers. Through the lens ofthe renewed essential public health functions framework, Bascolo et al. (p. S615) reviewed the institutional capacities of several health authorities in Latin American countries to respond to the needs of their populations during the COVID-19 pandemic before vaccination programs started.

SELECTION OF CITATIONS
SEARCH DETAIL